Literature DB >> 10843532

High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland.

J Böni1, H Pyra, M Gebhardt, L Perrin, P Bürgisser, L Matter, W Fierz, P Erb, J C Piffaretti, E Minder, P Grob, J J Burckhardt, M Zwahlen, J Schüpbach.   

Abstract

HIV-1 subtypes were determined in newly diagnosed residents of Switzerland. Blood was anonymously collected from patients with a first confirmed positive HIV-1 test result. Viral DNA from the env V3-V5 region was amplified by nested polymerase chain reaction (PCR) and screened for subtype B by heteroduplex mobility assay. All amplicons not identified as B were sequenced. From November 1996 to February 1998, 206 samples were analyzed. Main transmission risks were unprotected heterosexual (55.7%) or homosexual (27.1%) sexual contact or intravenous drug use (12.9%). Subtype B dominated in patients of Swiss, other European, American, or Asian citizenship; particularly high frequencies were found in homosexuals (97%) and drug users (94%). Non-B subtypes including A, C, D, E, F, G, H, a possible B/F recombinant, and a sequence related to J were present in 28.2% (95% confidence interval [CI], 22.9%-35.0%). Non-B were frequent in African citizens (95%), heterosexually infected individuals (44%), and women (43%). Heterosexually infected Swiss males harbored non-B strains in 18% and females in 33%. The results document a change in the epidemiology of newly diagnosed HIV-1 infections in Switzerland: predominance of heterosexual transmission and a high frequency of non-B subtypes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10843532     DOI: 10.1097/00126334-199910010-00010

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  12 in total

1.  Resistance-associated mutations in the human immunodeficiency virus type 1 subtype c protease gene from treated and untreated patients in the United Kingdom.

Authors:  P A Cane; A de Ruiter; P Rice; M Wiselka; R Fox; D Pillay
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

2.  Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.

Authors:  Regina B Osih; Patrick Taffé; Martin Rickenbach; Angèle Gayet-Ageron; Luigia Elzi; Christoph Fux; Milos Opravil; Enos Bernasconi; Patrick Schmid; Huldrych F Günthard; Matthias Cavassini
Journal:  AIDS Res Hum Retroviruses       Date:  2010-10-07       Impact factor: 2.205

3.  Characteristics of patients recently infected with HIV-1 non-B subtypes in France: a nested study within the mandatory notification system for new HIV diagnoses.

Authors:  Denys Brand; Alain Moreau; Françoise Cazein; Florence Lot; Josiane Pillonel; Sylvie Brunet; Damien Thierry; Stéphane Le Vu; Jean-Christophe Plantier; Caroline Semaille; Francis Barin
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

4.  Performance of three commercial viral load assays, Versant human immunodeficiency virus type 1 (HIV-1) RNA bDNA v3.0, Cobas AmpliPrep/Cobas TaqMan HIV-1, and NucliSens HIV-1 EasyQ v1.2, testing HIV-1 non-B subtypes and recombinant variants.

Authors:  Africa Holguín; Marisa López; Mar Molinero; Vincent Soriano
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

5.  Rapid detection of human immunodeficiency virus type 1 subtype e infection by PCR.

Authors:  Mao-Yuan Chen; Wei-Kung Wang; Ming-Cheng Lee; Shing-Jer Twu; Shiow-Ing Wu; Chun-Nan Lee
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

6.  Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection.

Authors:  Roger D Kouyos; Viktor von Wyl; Sabine Yerly; Jürg Böni; Philip Rieder; Beda Joos; Patrick Taffé; Cyril Shah; Philippe Bürgisser; Thomas Klimkait; Rainer Weber; Bernard Hirschel; Matthias Cavassini; Andri Rauch; Manuel Battegay; Pietro L Vernazza; Enos Bernasconi; Bruno Ledergerber; Sebastian Bonhoeffer; Huldrych F Günthard
Journal:  Clin Infect Dis       Date:  2011-01-10       Impact factor: 9.079

7.  Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Authors:  Dimitrios Paraskevis; Oliver Pybus; Gkikas Magiorkinis; Angelos Hatzakis; Annemarie Mj Wensing; David A van de Vijver; Jan Albert; Guiseppe Angarano; Birgitta Asjö; Claudia Balotta; Enzo Boeri; Ricardo Camacho; Marie-Laure Chaix; Suzie Coughlan; Dominique Costagliola; Andrea De Luca; Carmen de Mendoza; Inge Derdelinckx; Zehava Grossman; Osama Hamouda; Im Hoepelman; Andrzej Horban; Klaus Korn; Claudia Kücherer; Thomas Leitner; Clive Loveday; Eilidh Macrae; I Maljkovic-Berry; Laurence Meyer; Claus Nielsen; Eline Lm Op de Coul; Vidar Ormaasen; Luc Perrin; Elisabeth Puchhammer-Stöckl; Lidia Ruiz; Mika O Salminen; Jean-Claude Schmit; Rob Schuurman; Vincent Soriano; J Stanczak; Maja Stanojevic; Daniel Struck; Kristel Van Laethem; M Violin; Sabine Yerly; Maurizio Zazzi; Charles A Boucher; Anne-Mieke Vandamme
Journal:  Retrovirology       Date:  2009-05-20       Impact factor: 4.602

8.  HIV-1 genetic diversity in antenatal cohort, Canada.

Authors:  Bertine S Akouamba; Janique Viel; Hugues Charest; Natacha Merindol; Johanne Samson; Normand Lapointe; Bluma G Brenner; Richard Lalonde; P Richard Harrigan; Marc Boucher; Hugo Soudeyns
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

9.  Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy.

Authors:  Luigi Buonaguro; Annacarmen Petrizzo; Maria Tagliamonte; Francesca Vitone; Maria Carla Re; Elisabetta Pilotti; Claudio Casoli; Costanza Sbreglia; Oreste Perrella; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Infect Agent Cancer       Date:  2008-10-10       Impact factor: 2.965

Review 10.  Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example.

Authors:  Luigi Buonaguro; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro
Journal:  Retrovirology       Date:  2007-05-21       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.